Siva Kumar Kolluri

Title: Siva Kumar Kolluri: Innovator in Immunology and Cancer Therapeutics

Introduction

Siva Kumar Kolluri is a prominent inventor based in Corvallis, OR (US). He has made significant contributions to the fields of immunology and cancer therapeutics. With a total of 4 patents, his work focuses on developing innovative solutions for complex medical challenges.

Latest Patents

Kolluri's latest patents include the development of aryl hydrocarbon receptor activators. These small molecule AhR ligands are designed to induce the differentiation of Tr1 cells, which can suppress pathogenic immune responses without causing nonspecific immune suppression. Additionally, he has disclosed methods for treating autoimmune diseases using these AhR ligands. Another notable patent involves small molecule Bcl-2 functional converters as cancer therapeutics. This patent provides methods for inducing growth inhibition or apoptosis of Bcl-2-expressing cells, along with treatments for Bcl-2 expressing cancers. Furthermore, it includes assays for agents that can induce apoptosis of Bcl-2 expressing cells.

Career Highlights

Siva Kumar Kolluri is affiliated with Oregon State University, where he continues to advance his research and innovation in the medical field. His work has garnered attention for its potential impact on treating autoimmune diseases and cancers.

Collaborations

Kolluri collaborates with esteemed colleagues such as Prasad R Kopparapu and Martin Pearce. Their combined expertise enhances the research efforts and contributes to the development of groundbreaking therapies.

Conclusion

Siva Kumar Kolluri is a dedicated inventor whose work in immunology and cancer therapeutics is paving the way for new treatment options. His innovative patents reflect a commitment to addressing critical health challenges.